Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

Completed · Phase 2

Conditions studied: Dysmenorrhea, Dyspareunia, Endometriosis, Pelvic Pain

In brief

The purpose of the study is to evaluate the efficacy and safety of two doses of ERB-041 (75 mg and 150 mg) relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pain, and deep dyspareunia) in reproductive aged women.

Key facts

Study ID

NCT00318500

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

150

Starts

2006-05-01

Expected to finish

2006-12-01

Last updated by the study team

2007-12-10

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Surgical diagnosis of endometriosis within the last 10 years
• Sexually active, nonpregnant, nonlactating women (18-45 years) with regular menstrual cycles who are willing to use non-hormonal contraception

You may not qualify if…

• Conditions requiring the use of chronic pain therapy
• Prophylactic use of analgesics to avoid endometriosis-related pain

Where it is running

• Study site — Chandler, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — San Francisco, California, United States
• Study site — Vista, California, United States
• Study site — Denver, Colorado, United States
• Study site — Denver, Colorado, United States
• Study site — New Britain, Connecticut, United States
• Study site — Clearwater, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Plantation, Florida, United States
• Study site — Venice, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Marietta, Georgia, United States
• Study site — Idaho Falls, Idaho, United States
• Study site — Oak Brook, Illinois, United States
• Study site — Evansville, Indiana, United States
• Study site — Reno, Nevada, United States
• Study site — Lawrenceville, New Jersey, United States
• Study site — Durham, North Carolina, United States
• Study site — New Bern, North Carolina, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Montgomery, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.